Intravitreal dexamethasone for the treatment of macular edema secondary to hydroxychloroquine toxicity

Author:

Zeleny Alexander1,Mathai Mariam2,Jacobsen Bradley H.2,Garfinkel Richard A.2,Katira Reshma2,Fein Jordana G.2ORCID

Affiliation:

1. Georgetown University School of Medicine, 3800 Reservoir Rd NW, Washington, DC 20007

2. The Retina Group of Washington, 8270 Willow Oaks Corporate Drive, 6th Floor Fairfax, VA 22031, U.S.A.

Abstract

Abstract Purpose: Cystoid macular edema is a vision threatening complication infrequently associated with hydroxychloroquine retinal toxicity. There is limited data on the best treatment for this pathology. Methods: A retrospective case series is presented. Results: In this series, we present three cases of cystoid macular edema in patients with diagnosed hydroxychloroquine maculopathy successfully treated with intravitreal dexamethasone implantation. Conclusions Minimal literature has been published regarding the best management of cystoid macular edema related to hydroxychloroquine toxicity. Our case series suggests a possible new agent in the treatment of this rare occurrence.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference10 articles.

1. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy;Melles;JAMA Ophthalmol,2014

2. Hydroxychloroquine retinopathy;Yusuf;Eye (Lond),2017

3. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea;de Sisternes;Invest Opthalmology Vis Sci,2015

4. Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation;Kellner;Br J Ophthalmol,2014

5. Nonleaking cystoid macular edema as a presentation of hydroxychloroquine retinal toxicity;Parikh;Ophthalmology,2016

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3